INSPIREMD, INC. (NSPR)
InspireMD to Announce Second Quarter 2026 Financial Results
C4 THERAPEUTICS, INC. (CCCC)
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MESA LABORATORIES INC /CO/ (MLAB)
Mesa Labs Announces First Quarter Results
BRIDGEBIO PHARMA, INC. (BBIO)
BridgeBio Reports Second Quarter 2026 Financial Results and Corporate Updates
NVIDIA CORP (NVDA)
NVIDIA Partners With Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs and KKR to Establish AI Compute Infrastructure Financing Platforms to Mobilize Over $500 Billion of Third-Party Capital
ERASCA, INC. (ERAS)
Erasca Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
IN8BIO, INC. (INAB)
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GALAPAGOS NV (LKFT)
Lakefront Biotherapeutics rapporteert halfjaarcijfers 2026 en geeft een update over de activiteiten
Silence Therapeutics, Plc. (SLNCF)
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
ENANTA PHARMACEUTICALS INC (ENTA)
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026